Estradiol inhibits vascular endothelial cells pro-inflammatory activation induced by C-reactive protein
Open Access
- 31 October 2012
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 373 (1-2) , 137-147
Abstract
In addition of being an important inflammatory biomarker and a risk factor for cardiovascular disease, much evidence indicates that the C-reactive protein (CRP) contributes to the atherosclerosis development process. This plasmatic protein synthesized by hepatocytes in response to inflammation and tissue injury induces pro-inflammatory molecules' expression by endothelial cells (ECs). Previous studies showed that the 17β-estradiol (E2) has beneficial effects on vascular cells by reducing in vitro pro-inflammatory molecules expressions in EC. Therefore, we hypothesize that E2 blocks or reduces CRP-mediated inflammatory responses by modulating endogenous production of CRP in EC and/or activation mechanisms. Using human aortic ECs (HAECs), we first evaluated CRP production by vascular EC and second demonstrated its self-induction. Indeed, recombinant human CRP stimulation induces a fivefold increase of CRP expression. A 1-h pre-treatment of E2 at a physiologic dose (10−9 M) leads to an important decrease of CRP production suggesting a partial blockage of its amplification loop mechanism. Furthermore, in HAEC, E2 reduces the secretion of the most potent agonist of CRP induction, the IL-6, by 21 %. E2 pre-treatment also decreased the expression of pro-inflammatory molecules IL-8, VCAM-1, and ICAM-1 induced by CRP and involved in leukocytes recruitment. In addition, we demonstrated that E2 could restore vascular endothelial growth factor-mediated EC migration response impaired by CRP suggesting another pro-angiogenic property of this hormone. These findings suggest that E2 can interfere with CRP pro-inflammatory effects via activation signals using its rapid, non-genomic pathway that may provide a new mechanism to improve vascular repair.Keywords
This publication has 62 references indexed in Scilit:
- Endothelial Function as a Functional Expression of Cardiovascular Risk FactorsBiomarkers in Medicine, 2010
- Estrogen and Mechanisms of Vascular ProtectionArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- The Evolving Role of C-Reactive Protein in AtherothrombosisClinical Chemistry, 2009
- C-Reactive Protein Downregulates Endothelial NO Synthase and Attenuates Reendothelialization In Vivo in MiceCirculation Research, 2007
- Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterusJournal of Endocrinology, 2006
- C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferationCardiovascular Research, 2005
- C-reactive protein decreases expression of VEGF receptors and neuropilins and inhibits VEGF165-induced cell proliferation in human endothelial cellsBiochemical and Biophysical Research Communications, 2005
- Effect of C-reactive protein on chemokine expression in human aortic endothelial cellsJournal of Molecular and Cellular Cardiology, 2004
- 17β-estradiol inhibits the adhesion of leukocytes in TNF-α stimulated human endothelial cells by blocking IL-8 and MCP-1 secretion, but not its transcriptionLife Sciences, 2002
- Elevation of C-reactive protein in “active” coronary artery diseaseThe American Journal of Cardiology, 1990